Shah, Z., Yu, H., Afridi, S. S., Yao, S., Gandhi, S., Kabraji, S. K. (2026). Real-world brain metastasis outcomes with T-DXd versus tucatinib-based therapy in second-line HER2-positive metastatic breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1051